Patel B - Search Results

1

Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.

Kumar S, Jaller D, Patel B, LaLonde JM, DuHadaway JB, Malachowski WP, Prendergast GC, Muller AJ. Kumar S, et al. Among authors: patel b. J Med Chem. 2008 Aug 28;51(16):4968-77. doi: 10.1021/jm800512z. Epub 2008 Jul 30. J Med Chem. 2008. PMID: 18665584 Free PMC article.

2

Design, synthesis and anti-HIV activity of novel quinoxaline derivatives.

Patel SB, Patel BD, Pannecouque C, Bhatt HG. Patel SB, et al. Among authors: patel bd. Eur J Med Chem. 2016 Jul 19;117:230-40. doi: 10.1016/j.ejmech.2016.04.019. Epub 2016 Apr 11. Eur J Med Chem. 2016. PMID: 27105027

3

Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.

Jain PG, Patel BD. Jain PG, et al. Eur J Med Chem. 2019 Mar 1;165:198-215. doi: 10.1016/j.ejmech.2019.01.024. Epub 2019 Jan 12. Eur J Med Chem. 2019. PMID: 30684797 Review.

4

Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer.

Chaube U, Dey R, Shaw S, Patel BD, Bhatt HG. Chaube U, et al. Future Med Chem. 2022 Dec;14(23):1789-1809. doi: 10.4155/fmc-2022-0204. Epub 2022 Dec 20. Future Med Chem. 2022. PMID: 36538021 Review.

5

Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors.

Patel BD, Ghate MD. Patel BD, et al. Eur J Med Chem. 2014 Mar 3;74:574-605. doi: 10.1016/j.ejmech.2013.12.038. Epub 2014 Jan 11. Eur J Med Chem. 2014. PMID: 24531198 Review.

6

Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.

Patel BD, Bhadada SV, Ghate MD. Patel BD, et al. Bioorg Chem. 2017 Jun;72:345-358. doi: 10.1016/j.bioorg.2017.03.004. Epub 2017 Mar 6. Bioorg Chem. 2017. PMID: 28302310

7

Design of 2-Nitroimidazooxazine Derivatives as Deazaflavin-Dependent Nitroreductase (Ddn) Activators as Anti-Mycobacterial Agents Based on 3D QSAR, HQSAR, and Docking Study with In Silico Prediction of Activity and Toxicity.

Gupta N, Vyas VK, Patel BD, Ghate M. Gupta N, et al. Interdiscip Sci. 2019 Jun;11(2):191-205. doi: 10.1007/s12539-017-0256-1. Epub 2017 Sep 11. Interdiscip Sci. 2019. PMID: 28895050

8

Pharmacophore mapping based virtual screening, molecular docking and ADMET studies of ROCK II inhibitors.

Shah S, Patel B, Savjani JK. Shah S, et al. Among authors: patel b. Mult Scler Relat Disord. 2018 Apr;21:35-41. doi: 10.1016/j.msard.2018.02.011. Epub 2018 Feb 12. Mult Scler Relat Disord. 2018. PMID: 29455072 No abstract available.

9

Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.

Shah K, Panchal S, Patel B. Shah K, et al. Among authors: patel b. Pharmacol Res. 2021 May;167:105532. doi: 10.1016/j.phrs.2021.105532. Epub 2021 Mar 4. Pharmacol Res. 2021. PMID: 33677106 Review.

10

Multimodal Fusion Artificial Intelligence Model to Predict Risk for MACE and Myocarditis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy.

Ayoub C, Appari L, Pereyra M, Farina JM, Chao CJ, Scalia IG, Mahmoud AK, Abbas MT, Baba NA, Jeong J, Lester SJ, Patel BN, Arsanjani R, Banerjee I. Ayoub C, et al. Among authors: patel bn. JACC Adv. 2024 Dec 13;4(1):101435. doi: 10.1016/j.jacadv.2024.101435. eCollection 2025 Jan. JACC Adv. 2024. PMID: 39759436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,468 results

Search Page

Filters